Similar articles for PMID: 25773653

Year	Number of Results
1995	1
2003	1
2005	2
2006	2
2007	3
2008	4
2009	6
2010	9
2011	4
2012	4
2013	4
2014	5
2015	12
2016	2
2017	1
2024	0

1

Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group.

Buglione M, Borghetti P, Pedretti S, Triggiani L, Fontanella MM, Spena G, Grisanti S, Liserre R, Poliani LP, Gipponi S, Spiazzi L, Magrini SM. Buglione M, et al. Radiol Med. 2015 Oct;120(10):975-81. doi: 10.1007/s11547-015-0528-y. Epub 2015 Mar 15. Radiol Med. 2015. PMID: 25773653

2

Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.

Iaccarino C, Orlandi E, Ruggeri F, Nicoli D, Torricelli F, Maggi M, Cerasti D, Pisanello A, Pedrazzi G, Froio E, Crafa P, D'Abbiero N, Michiara M, Ghadirpour R, Servadei F. Iaccarino C, et al. Clin Neurol Neurosurg. 2015 May;132:1-8. doi: 10.1016/j.clineuro.2015.01.029. Epub 2015 Feb 7. Clin Neurol Neurosurg. 2015. PMID: 25723791

3

Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.

Ciammella P, Galeandro M, D'Abbiero N, Podgornii A, Pisanello A, Botti A, Cagni E, Iori M, Iotti C. Ciammella P, et al. Clin Neurol Neurosurg. 2013 Sep;115(9):1609-14. doi: 10.1016/j.clineuro.2013.02.001. Epub 2013 Feb 26. Clin Neurol Neurosurg. 2013. PMID: 23453151

4

Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.

Gerstein J, Franz K, Steinbach JP, Seifert V, Fraunholz I, Weiss C, Rödel C. Gerstein J, et al. Radiother Oncol. 2010 Dec;97(3):382-6. doi: 10.1016/j.radonc.2010.06.014. Epub 2010 Sep 17. Radiother Oncol. 2010. PMID: 20850883

5

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.

Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P. Athanassiou H, et al. J Clin Oncol. 2005 Apr 1;23(10):2372-7. doi: 10.1200/JCO.2005.00.331. J Clin Oncol. 2005. PMID: 15800329 Clinical Trial.

6

Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.

Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G. Panet-Raymond V, et al. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):473-8. doi: 10.1016/j.ijrobp.2008.04.030. Epub 2008 Jun 12. Int J Radiat Oncol Biol Phys. 2009. PMID: 18554821

7

Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.

Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A. Lanzetta G, et al. Anticancer Res. 2003 Nov-Dec;23(6D):5159-64. Anticancer Res. 2003. PMID: 14981983 Clinical Trial.

8

Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.

Kocher M, Frommolt P, Borberg SK, Rühl U, Steingräber M, Niewald M, Staar S, Stuschke M, Becker G, Fischedick AR, Herfarth K, Grauthoff H, Müller RP. Kocher M, et al. Strahlenther Onkol. 2008 Nov;184(11):572-9. doi: 10.1007/s00066-008-1897-0. Epub 2008 Nov 19. Strahlenther Onkol. 2008. PMID: 19016015 Clinical Trial.

9

Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.

Piroth MD, Gagel B, Pinkawa M, Stanzel S, Asadpour B, Eble MJ. Piroth MD, et al. Strahlenther Onkol. 2007 Dec;183(12):695-702. doi: 10.1007/s00066-007-1739-5. Strahlenther Onkol. 2007. PMID: 18040615

10

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F. Barbagallo GM, et al. Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502. Neurosurg Focus. 2014. PMID: 25434389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year